| |
|
|
|
Drug Information Association, Park Hyatt Philadelphia at the Bellevue, Philadelphia, USA
Apr 7 2008
This course is designed to provide an overview of US and international safety surveillance, including the role of epidemiology and risk management, from both industry and FDA perspectives. This overview is not a “how to” course in completing adverse event forms for regulatory reporting. Key TopicsThe role of epidemiology in safety surveillance Domestic and international safety surveillance Regulatory and industry perspectives on safety surveillance and epidemiology.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
1) Steven J. Blumenthal, MSAssociate Director, Safety Update ReportingMerck Research LaboratoriesUnited States 2) Linda S HostelleyVice President, Worldwide Product Safety and Quality AssuranceMerck & Co., Inc.United States 3) Judith M Sills, PharmDHead, Global Safety IntelligenceNovartis PharmaceuticalsUnited States 4) I. Sanford Smith, MDUnited States 5) Annette Stemhagen, DrPH, FISPEVice President, Epidemiology and Risk ManagementUnited Biosource CorporationUnited States.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16071&eventType=Training%20Course
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|